Nerve regeneration in diabetic neuropathy

Diabetes, Obesity and Metabolism

Volumn 1, Issue 1, 1999, Pages 3-11

  Apfel, Stuart C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL; DIABETIC NEUROPATHY; HUMAN; NERVE DEGENERATION; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETIC NEUROPATHIES; HUMANS; NERVE DEGENERATION; NERVE GROWTH FACTOR; NERVE REGENERATION;

EID: 0032601004     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.1999.00006.x     Document Type: Review

References (70)

1. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-188.
2. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffen JW, Low PA, Poduslo JF, eds, Peripheral Neuropathy, 3rd edn. Philadelphia: W.B. Saunders, 1993: 1219-1250.
3. Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 1997; 46(Suppl.): S54-S57.
4. Thomas PK. Metabolic neuropathy. J Roy Coll Phys Lon 1973; 7: 154-160.
5. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurolog Neurosurg Psych 1983; 46: 491-499.
6. Pourmand R. Diabetic neuropathy. Neurologic Clin 1997; 15: 569-576.
7. Low PA, Tuck RR, Takeuchi M. Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Winegrad AI, Porte D, eds, Diabetic Neuropathy. Philadelphia: W.B. Saunders, Co., 1987: 266-278.
8. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425-439.
9. Feldman EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuroapthy. Clin Neurosci 1997; 4: 365-370.
10. Stevens JJ, Lattimer SA, Kamijo M, VanHuysen C, Sima AAF, Greene DA. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia, 1993: 36: 608-614.
11. Greene DA, Lattimer SA. Impaired rat sciatic nerve sodium-potasium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 1983; 72: 1058-1063.
12. Brewster WJ, Fernyhough P, Diemel LT, Mohiaddin L, Tomlinson DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994; 17: 321-325.
13. Jakobsen J, Brimijoin S, Sklau K, Sidenius P, Wells D. Retrograde axonal transport of transmitter enzymes, fucose labelled protein and nerve growth factor in streptozocin diabetic rats. Diabetes 1981; 30: 797-803.
14. Hellweg R, Raivich G, Hartung H-D, Hock C, Kreutzberg GW. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 1994; 130: 24-30.
15. Hellweg R, Hartung H-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990; 26: 258-267.
16. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 1996; 2: 703-707.
17. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1996; 55: 1181-1193.
18. Bradley JL, Thomas PK, King RH, et al. Myelinated nerve fiber regeneration in diabetic sensory polyneuropathy: Correlation with type of neuropathy. Acta Neuropathol (Berlin) 1995; 90: 403-410.
19. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824.
20. Bisby MA. Axonal transport of labeled protein and regeneration rate in nerve of streptozocin-diabetic rats. Exp Neurol 1980; 69: 74-84.
21. Longo FM, Powell HC, Lebeau J, Gerrero MR, Heckman H, Myers RR. Delayed nerve regeneration in streptozocin diabetic rats. Muscle Nerve 1986; 9: 385-393.
22. Tantuwaya VS, Bailey SB, Schmidt RE, Villadiego A, Tong JX, Rich KM. Peripheral nerve regeneration through silicone chambers in streptozocin-induced diabetic rats. Brain Res 1997; 759: 58-66.
23. Griffin JW, George R, Lobato C, Tyor WR, Yan LC, Glass JD. Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination. J Neuroimmunol 1992; 40: 153-165.
24. Brecknell JE, Fawcett JW. Axonal regeneration. Biological Rev 1996; 71: 227-255.
25. Perry VH, Brown MC. Role of macrophages in peripheral nerve regeneration and repair. Bioessays 1992; 14: 401-406.
26. Anderson PN, Mitchell J, Mayor D, Stauber W. An ultrastructural study of the early stages of axonal regeneration through rat nerve grafts. Neuropathol Appl Neurobiol 1983; 9: 455-466.
27. Ide C, Tohyama K, Yokota R, Nitatori T, Onodepa H. Schwann cell basal lamina and nerve regeneration. Brain Res 1983; 288: 61-65.
28. Feneley MR, Fawcett JW, Keyenes RJ. The role of Schwann cells in the regeneration of peripheral nerve axons through muscle basal lamina grafts. Exp Neurol 1991; 114: 275-285.
29. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of the rat sciatic nerve. Nature 1987; 330: 658-659.
30. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326.
31. Heumann R, Korsching S, Bandtlow C, Thoenen H. Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection. J Cell Biol 1987; 104: 1623-1631.
32. Taniuchi M, Clark MB, Johnson EM. Induction of nerve growth factor receptor in Schwann cells after axotomy. Proceed Nat Acad Sci USA 1986; 83: 4094-4098.
33. Verge VMK, Riopelle RJ, Richardson PM. Nerve growth factor receptors on normal and injured sensory neurons. J Neurosci 1989; 9: 914-922.
34. Funakoshi H, Frisen J, Barbany G, et al. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993; 123: 455-465.
35. Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H. Enhanced synthesis of brain derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992; 119: 45-54.
36. Sebert ME, Shooter EM. Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury. J Neurosci Res 1993; 36: 357-367.
37. Apfel SC, Wright DE, Wiideman AM, Dormia C, Snider WD, Kessler JA. Nerve growth factor regulates the expression of brain derived neurotrophic factor mRNA in the peripheral nervous system. Mol Cell Neurosci 1996; 7: 134-142.
38. Michael GJ, Averill S, Nitkunan A, et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 1997; 17: 8476-8490.
39. Tonra JR, Curtis R, Wong V, et al. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J Neurosci 1998; 18: 4374-4383.
40. Pruginin-Bluger M, Shelton DL, Kalcheim C. A paracrine effect of neuron-derived BDNF in development of dorsal root ganglia: stimulation of Schwann cell myelin protein expression by glial cells. Mech Develop 1997; 61: 99-111.
41. Hellweg R, Hartung H-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990; 26: 258-267.
42. Hellweg R, Raivich G, Hartung H-D, Hock C, Kreutzberg GW. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 1994; 130: 24-30.
43. Jakobsen J, Brimijoin S, Sklau K, Sidenius P, Wells D. Retrograde axonal transport of transmitter enzymes, fucose labelled protein and nerve growth factor in streptozocin diabetic rats. Diabetes 1981; 30: 797-803.
44. Ordonez G, Fernandez A, Perez R, Sotelo J. Low contents of nerve growth factor in serum and submaxillary glands of diabetic mice. J Neurol Sci 1994; 121: 163-166.
45. Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 1990; 81: 402-406.
46. Brewster WJ, Fernyhough P, Diemel LT, Mohiaddin L, Tomlinson DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994; 17: 321-325.
47. Hellweg R, Wohrle M, Hartung H-D, Stracke H, Hock C, Federlin K.Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation. Neurosci Lett 1991; 125: 1-4.
48. NGFR. Mol Brain Res 1996; 37: 166-174.
49. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 1996; 2: 703-707.
50. Woolf CJ, Reynolds ML, O'Brien C, Lindsay R.M, Benowitz LI. The growth associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience 1990; 34: 465-478.
51. Meiri KF, Gordon-Weeks PR. GAP-43 in growth cones is associated with areas of membrane that are tightly bound to substrate and is a component of a membrane skeleton subcellular fraction. J Neurosci 1990; 10: 256-266.
52. Lankford KL, Kenney AM, Kocsis JD. Cellular mechanisms regulating neurite initiation. In: Mize RR, Erzzurumlu RS, eds, Progress in Brain Research. Elsevier Science, 1996: 55-81.
53. Pekiner C, Dent EW, Roberts RE, Meiri KE, McLean G. Altered GAP-43 irnmunoreactivity in regenerating sciatic nerve of diabetic rats. Diabetes 1996; 45: 199-204.
54. Mohiuddin L, Tomlinson DR. Impaired molecular regenerative responses in sensory neurones of diabetic rats: Gene expression changes in dorsal root ganglia after sciatic nerve crush. Diabetes 1997; 46; 2057-2062.
55. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 1994; 23: 1-28.
56. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.
57. Diabetes Control and Complications Trial (DCCT) Research Group. Effect offensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol 1995; 38: 869-880.
58. Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: The end of an era or the need for different trial designs? Diabetes 1997; 46(Suppl.): S82-S89.
59. Love A, Cotter MA, Cameron NE. unpaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway. Brain Res 1995; 703: 105-110.
60. Kamijo M, Merry AC, Akdas G, Cherian PV, Sima AA. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treament. J Diabetes Complications 1996; 10: 183-191.
61. Sima AAF, Greene DA, Brown MB, et al. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. J Diabetes Complications 1993; 7: 157-169.
62. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994; 634: 7-12.
63. Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 1998; 51: 695-702.
64. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321-362.
65. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth stimulating factor isolated from sarcomas 37 and 180. Proceed Nat Acad Sci USA 1954; 40: 1014-1018.
66. Derby A, Engleman VW, Frierdich GE, Neises G, Rapp SR, Roufa DG. Nerve growth factor facilitates regeneration across nerve gaps: morphological and behavioral studies in rat sciatic nerve. Exp Neurol 1993; 119: 176-191.
67. Santos PM, Winterowd JG, Allen GG, Bothwell MA, Rubel EW. Nerve growth factor: increase angiogenesis without improved nerve regeneration. Otolaryngol Head Neck Surg 1991; 105: 12-25.
68. Diamond J, Foerster A, Holmes M, Coughlin M. Sensory nerves in the adult rat regenerate and restore sensory function to the skin independently of endogenous NGF. J Neurosci 1992; 12: 1467-1476.
69. Gold BG. Axonal regeneration of sensory nerves is delayed by continuous intrathecal infusion of nerve growth factor. Neuroscience 1997; 76: 1153-1158.
70. Zhuang H-X, Snyder CK, Pu S-F, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996; 140: 198-205.